213 related articles for article (PubMed ID: 17507470)
21. Amino acid residues on human poliovirus receptor involved in interaction with poliovirus.
Aoki J; Koike S; Ise I; Sato-Yoshida Y; Nomoto A
J Biol Chem; 1994 Mar; 269(11):8431-8. PubMed ID: 8132569
[TBL] [Abstract][Full Text] [Related]
22. Retrograde axonal transport of poliovirus and EV71 in motor neurons.
Ohka S; Hao Tan S; Kaneda S; Fujii T; Schiavo G
Biochem Biophys Res Commun; 2022 Oct; 626():72-78. PubMed ID: 35973377
[TBL] [Abstract][Full Text] [Related]
23. The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice.
Abe Y; Fujii K; Nagata N; Takeuchi O; Akira S; Oshiumi H; Matsumoto M; Seya T; Koike S
J Virol; 2012 Jan; 86(1):185-94. PubMed ID: 22072781
[TBL] [Abstract][Full Text] [Related]
24. Reduction of the rate of poliovirus protein synthesis through large-scale codon deoptimization causes attenuation of viral virulence by lowering specific infectivity.
Mueller S; Papamichail D; Coleman JR; Skiena S; Wimmer E
J Virol; 2006 Oct; 80(19):9687-96. PubMed ID: 16973573
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of the cellular receptor for poliovirus.
Bernhardt G; Bibb JA; Bradley J; Wimmer E
Virology; 1994 Feb; 199(1):105-13. PubMed ID: 8116232
[TBL] [Abstract][Full Text] [Related]
26. Multiple host barriers restrict poliovirus trafficking in mice.
Kuss SK; Etheredge CA; Pfeiffer JK
PLoS Pathog; 2008 Jun; 4(6):e1000082. PubMed ID: 18535656
[TBL] [Abstract][Full Text] [Related]
27. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses.
Cello J; Toyoda H; Dejesus N; Dobrikova EY; Gromeier M; Wimmer E
J Med Virol; 2008 Feb; 80(2):352-9. PubMed ID: 18098139
[TBL] [Abstract][Full Text] [Related]
28. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
[TBL] [Abstract][Full Text] [Related]
29. Effect of formaldehyde inactivation on poliovirus.
Wilton T; Dunn G; Eastwood D; Minor PD; Martin J
J Virol; 2014 Oct; 88(20):11955-64. PubMed ID: 25100844
[TBL] [Abstract][Full Text] [Related]
30. The promoters for human and monkey poliovirus receptors. Requirements for basic and cell type-specific activity.
Solecki D; Schwarz S; Wimmer E; Lipp M; Bernhardt G
J Biol Chem; 1997 Feb; 272(9):5579-86. PubMed ID: 9038165
[TBL] [Abstract][Full Text] [Related]
31. The human poliovirus receptor. Receptor-virus interaction and parameters of disease specificity.
Gromeier M; Lu HH; Bernhardt G; Harber JJ; Bibb JA; Wimmer E
Ann N Y Acad Sci; 1995 May; 753():19-36. PubMed ID: 7611627
[TBL] [Abstract][Full Text] [Related]
32. Recent insights into poliovirus pathogenesis.
Ohka S; Nomoto A
Trends Microbiol; 2001 Oct; 9(10):501-6. PubMed ID: 11597452
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon.
Arita M; Nagata N; Sata T; Miyamura T; Shimizu H
J Gen Virol; 2006 Nov; 87(Pt 11):3317-3327. PubMed ID: 17030866
[TBL] [Abstract][Full Text] [Related]
34. Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication.
Jiang P; Faase JA; Toyoda H; Paul A; Wimmer E; Gorbalenya AE
Proc Natl Acad Sci U S A; 2007 May; 104(22):9457-62. PubMed ID: 17517601
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of poliovirus infection in PVRTg mice: poliovirus replicates in peritoneal macrophages.
Buisman AM; Sonsma JAJ; van Wijk MGS; Vermeulen JP; Roholl PJ; Kimman TG
J Gen Virol; 2003 Oct; 84(Pt 10):2819-2828. PubMed ID: 13679616
[TBL] [Abstract][Full Text] [Related]
36. Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains.
Martín J; Crossland G; Wood DJ; Minor PD
J Gen Virol; 2003 Jul; 84(Pt 7):1781-1788. PubMed ID: 12810872
[TBL] [Abstract][Full Text] [Related]
37. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
Horie H; Koike S; Kurata T; Sato-Yoshida Y; Ise I; Ota Y; Abe S; Hioki K; Kato H; Taya C
J Virol; 1994 Feb; 68(2):681-8. PubMed ID: 8289371
[TBL] [Abstract][Full Text] [Related]
38. A Transgenic Mouse Model of Poliomyelitis.
Koike S; Nagata N
Methods Mol Biol; 2016; 1387():129-44. PubMed ID: 26983733
[TBL] [Abstract][Full Text] [Related]
39. Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection.
Labadie K; Saulnier A; Martin-Latil S; Colbère-Garapin F
J Virol; 2007 Mar; 81(6):3033-6. PubMed ID: 17192301
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
